1. OpenAI Unveils Rosalind: A Powerful, Restricted AI Model for Drug Discovery
OpenAI has launched its first domain-specific artificial intelligence model, but its capabilities are locked behind a wall of exclusivity. Named GPT-Rosalind, the system is engineered specifically for the high-stakes fields of drug discovery and life sciences, representing a targeted move beyond the company's general-p...